SK Bioscience Co. Ltd. (302440.KS), a South Korean biotechnology company, on Monday reported a third-quarter net profit of KRW 21.083 billion, compared with a net loss of KRW 22.317 billion in the same period last year.
Operating loss stood at KRW 19.371 billion as against the prior year's loss of KRW 39.614 billion. Revenue was KRW 150.765 billion, up from the previous year's KRW 61.648 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.